E Psychedelic Drug Stocks Index Continued To Appreciate Last Week

TM Editors Note: Many of the companies mentioned in this article are penny stocks and/or microcaps. Such stocks are readily manipulated; do your own careful due diligence.

This article tracks the performance of 15 of the 35 biopharmaceutical companies involved in the research and development of psychedelic compounds to treat mental health issues such as obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, depression, anxiety, and eating disorders in the munKNEE Pure-Play Psychedelic Drug Stocks Index.

Index Inclusion Criteria

The 15 stocks eligible for inclusion in the index are based on the following criteria:

  • a market capitalization between US$20M and US$200M (current average Market Cap is US$44M)
  • a stock that trades between US$0.20/share and US$2/share (current average Stock Price is US$0.85/share)

Below are the 15 eligible companies in the munKNEE Pure-Play Psychedelic Drug Stocks Index and their performance for the first week of January, 2021. All prices are in USD unless otherwise noted.

  1. Champignon (SHRMF) +1.6% to $0.63/share
  2. Cybin (CLXPF+4.7% to $1.57/share
  3. Havn (HAVLF) -6.5% to $0.72/share
  4. Hollister (HSTRF+30.0% to $0.26/share
  5. Jaguar (JAGX) +393.8% to $4.00/share
    • Jaguar Health's stock price continues to climb (up 1900% since the end of October) as a result of management's announcement of its plan to develop and commercialize crofelemer, a new drug aimed at helping people with inflammatory diarrhea, including those who have recovered from COVID-19 but still experiencing symptoms.
  6. Mind Cure (MCURF+1.8% to $0.58/share
  7. Mydecine (MYCOF) -2.9% to $0.34/share
  8. Newscope (PHRM) +6.3% to C$0.34/share
  9. Numinus (LKYSF+16.7% to $0.98/share
  10. Psyched (DCNPF+4.5% to $0.23/share
  11. Red Light (TRUFF) N/C @ $0.24/share 
  12. Revive (RVVTF) N/C @ $0.48/share
  13. Seelos (SEEL) -8.9% to $1.44/share
  14. Silo Pharma (SILO) -16.7% to $0.35/share
  15. Tryp (TRYP) -16.0% to C$0.63/share
1 2
View single page >> |

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.